VR Adviser »

Adlai Nortye Ltd Sponsored shares owned by VR Adviser

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by VR Adviser

Quarter filed Position value Share count Share price at filing
2026-03-31 $22M 3.2M 6.92

More positions owned by VR Adviser

Apogee Therapeutics (APGE)
Erasca (ERAS)
Oruka Therapeutics (ORKA)
Spyre Therapeutics Com New (SYRE)
Kalvista Pharmaceuticals (KALV)
Dianthus Therapeutics (DNTH)
Damora Therapeutics Com New (DMRA)
Ocular Therapeutix (OCUL)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Savara (SVRA)
Enliven Therapeutics (ELVN)
Oric Pharmaceuticals (ORIC)
Vor Biopharma Com New (VOR)
Maze Therapeatics (MAZE)

View all positions for VR Adviser

Top funds holding Adlai Nortye Ltd Sponsored

VR Adviser
Cormorant Asset Management
Squadron Capital Management
Balyasny Asset Management
Millennium Management
Casdin Capital
Woodline Partners
UBS Group
Ameriprise Financial
ADAR1 Capital Management
Toroso Investments
Cantor Fitzgerald, L. P.
TD Asset Management
Ikarian Capital
Persistent Asset Partners

View all funds holding Adlai Nortye Ltd Sponsored